InnovAge (OTCMKTS:INNV) Stock Price Crosses Below 50-Day Moving Average of $4.48

InnovAge Holding Corp. (OTCMKTS:INNVGet Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $4.48 and traded as low as $3.70. InnovAge shares last traded at $3.72, with a volume of 112,314 shares changing hands.

InnovAge Stock Performance

The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.25. The firm has a 50-day moving average of $4.48 and a 200-day moving average of $5.25. The stock has a market capitalization of $505.54 million, a price-to-earnings ratio of -14.88 and a beta of 0.15.

InnovAge (OTCMKTS:INNVGet Free Report) last released its earnings results on Tuesday, February 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.03). The firm had revenue of $188.90 million for the quarter, compared to the consensus estimate of $181.51 million. InnovAge had a negative return on equity of 13.04% and a negative net margin of 6.17%. As a group, sell-side analysts predict that InnovAge Holding Corp. will post -0.25 earnings per share for the current year.

InnovAge Company Profile

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Featured Articles

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.